Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Seed Firm Bejo Takes License to Corteva Agriscience, Broad Institute CRISPR IP

NEW YORK — Dutch vegetable seed firm Bejo said this week that it has acquired a nonexclusive license to CRISPR-Cas9 intellectual property from Corteva Agriscience and the Broad Institute.

Under the terms of the license, Bejo can use the IP in its agriculture research and commercial programs. The company noted, however, that it will use the genome-editing technology for research only pending changes in legislation.

"Gene editing technologies like CRISPR-Cas9 bring opportunities for accelerating Bejo's vegetable breeding programs," Bert Schrijver, director of R&D at Bejo, said in a statement. "They increase our understanding of genetics and provide tools to develop new traits such as abiotic stress and disease resistance."

In 2017, DowDuPont — which spun off its agriculture business as Corteva in 2019 — and the Broad Institute agreed to jointly offer nonexclusive licenses to their respective CRISPR-Cas9 IP for commercial agricultural research and product development. Licensees of the technology include Yield10 and Amfora.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more